Inductive Characterization of ENDS-associated Adverse Events Among California Young Adults
AJPM Focus
; : 100040, 2022.
Article
in English
| ScienceDirect | ID: covidwho-2068989
ABSTRACT
Introduction:
Previous studies have identified numerous adverse events experienced with use of electronic nicotine delivery systems (ENDS), or e-cigarettes. Much remains unknown, however, about adverse event frequency, duration, and response experienced by users. The purpose of this study was to inductively characterize ENDS-attributed adverse events among young adults.Methods:
Sixteen focus groups were held with 114 young adults (18-29 years) who have reported lifetime ENDS use in April 2021. Discussion topics included current and previous tobacco, nicotine, and cannabis use;specific symptoms and frequency and duration of and response to symptoms ENDS-attributed adverse events;and the impact of other conditions such as COVID-19 on ENDS use. Data were inductively analyzed using a team-based approach.Results:
Over 40 ENDS-attributed adverse events were reported in focus groups among approximately three-quarters of all study participants with headache, coughing, lightheadedness, nausea, dry or sore throat, and dizziness the most common. In general, adverse events were transient with most resolving in a few hours though some tended to last for longer. Frequency of adverse events varied most between every time ENDS were used and when someone vaped excessively. Finally, behavioral responses varied by adverse event with difficulty breathing, chest pain, and lung discomfort more likely to result in quitting permanently.Conclusions:
Overall, the results of this study show that not only do adverse events vary greatly, but that they also vary across all multiple dimensions of user experience.
Full text:
Available
Collection:
Databases of international organizations
Database:
ScienceDirect
Language:
English
Journal:
AJPM Focus
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS